Estrous cycle modulates the anxiogenic effects of caffeine in the elevated plus maze and light/dark box in female rats.


Journal

Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872

Informations de publication

Date de publication:
10 09 2021
Historique:
received: 31 01 2021
revised: 10 06 2021
accepted: 14 07 2021
pubmed: 20 7 2021
medline: 15 2 2022
entrez: 19 7 2021
Statut: ppublish

Résumé

Caffeine is a commonly used stimulant of the central nervous system that reduces fatigue, increases alertness, and exerts positive effects on emotion through actions on various brain structures. High doses of caffeine can cause headaches, heart palpitations, hyperactivity, and anxiety symptoms. Consequently, reducing the consumption of stimulant substances, such as sugar and caffeine, is proposed to ameliorate symptoms of premenstrual syndrome in women. The administration of steroid hormones has been suggested to modulate the effects of caffeine, but unknown is whether endogenous hormone variations during the estrous cycle modulate the pharmacological effects of caffeine. The present study evaluated the effects of caffeine (10, 20, and 40 mg/kg) during metestrus-diestrus and proestrus-estrus of the ovarian cycle in rats on anxiety-like behavior using the elevated plus maze and light/dark box. During metestrus-diestrus, all doses of caffeine increased anxiety-like behavior, indicated by the main variables in both behavioral tests (i.e., higher Anxiety Index and lower percent time spent on the open arms in the elevated plus maze and less time spent in the light compartment in the light/dark box). During proestrus-estrus, only 20 and 40 mg/kg caffeine increased these parameters of anxiety-like behavior, albeit only slightly. In conclusion, caffeine increased anxiety-like behaviors in metestrus-diestrus, with an attenuation of these effects of lower doses of caffeine in proestrus-estrus. These effects that were observed in metestrus-diestrus and proestrus-estrus may be associated with low and high concentrations of steroid hormones, respectively, that naturally occur during these phases of the ovarian cycle.

Identifiants

pubmed: 34280462
pii: S0166-4328(21)00357-0
doi: 10.1016/j.bbr.2021.113469
pii:
doi:

Substances chimiques

Central Nervous System Stimulants 0
Caffeine 3G6A5W338E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113469

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Gabriel Guillén-Ruiz (G)

Cátedras CONACyT-Instituto de Neuroetología, Universidad Veracruzana, Xalapa, Veracruz, Mexico.

Jonathan Cueto-Escobedo (J)

Departamento de Investigación Clínica y Traslacional, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, Mexico.

Fabiola Hernández-López (F)

Unidad de Medicina Familiar No. 66, Instituto Mexicano del Seguro Social, Xalapa, Veracruz, Mexico.

Lina E Rivera-Aburto (LE)

Facultad de Química Farmacéutica Biológica, Universidad Veracruzana, Xalapa, Veracruz, Mexico.

Emma V Herrera-Huerta (EV)

Facultad de Ciencias Químicas, Universidad Veracruzana, Orizaba, Veracruz, Mexico.

Juan Francisco Rodríguez-Landa (JF)

Facultad de Química Farmacéutica Biológica, Universidad Veracruzana, Xalapa, Veracruz, Mexico; Laboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa, Veracruz, Mexico. Electronic address: juarodriguez@uv.mx.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH